Clinical trials recruiting for Antibody-drug Conjugates
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| SHR-A1811 | 1 |
| Trastuzumab Rezetecan | 1 |
Self-screener
Recruiting trials
- Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer
- Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies
Related conditions
Trials recruiting for Antibody-drug Conjugates often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Urachal Cancer 3HER2-low Breast Cancer 7Breast Neoplasms 105Advanced Solid Tumor Cancer 5
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Antibody-drug Conjugates trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.